265. Lipodystrophy Clinical trials / Disease details
Clinical trials : 116 / Drugs : 170 - (DrugBank : 61) / Drug target genes : 26 - Drug target pathways : 97
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03039491 (ClinicalTrials.gov) | September 1, 2015 | 30/1/2017 | Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults | Immune Response to Pneumococcal Vaccination in Aging HIV Positive Individuals | HIV Lipodystrophy;Aging | Biological: Pneumococcal polysaccharide vaccine 23 valent;Biological: 13 valent conjugated pneumococcal vaccine | Medical University of South Carolina | NULL | Completed | 21 Years | 65 Years | All | 160 | Early Phase 1 | United States |